CardioIQ
Methodology · How it works

How CardioIQ Reads Your Labs Against Optimal

No black box, no algorithm-of-the-week. Your report is built on the same guidelines cardiologists use — applied by a lipidologist, calibrated to your risk, and kept current as the evidence moves.

Built by a lipidologist, not a tech company

CardioIQ isn't a wellness app with a medical veneer. Its interpretation logic is built and maintained by a preventive cardiologist and lipidologist who does exactly this work in clinic — reading complex lipid and cardiometabolic panels against prevention-focused targets.

TG
Tea Gamezardashvili, MD, PhD, MHA, FACC
Preventive Cardiologist & Lipidologist · Founder
  • President, Georgian Atherosclerosis Association (GAA)
  • National Coordinator, EAS Lipid Clinic Network (Georgia)
  • Co-author, EAS consensus paper (Atherosclerosis, 2026)
  • Academic Director, CMEA

When your report says a number is above optimal, that judgment traces back to a named guideline and a physician who stands behind it — not an anonymous model tuned for engagement.

What “optimal” actually means — and where the targets come from

“Normal” on a lab report compares you to the population. Optimal asks a harder question: what level keeps your arteries on the lowest-risk path for the decades ahead — given your risk? That target isn't something we invent. It rests on three well-established ideas:

We take that evidence base — the same one preventive cardiologists work from — and make it legible for your specific numbers. The full framework → · Why ApoB →

How your report is built

Five steps, and no black box at any of them:

  1. Your numbers, organized. Your panel and risk factors are structured into a consistent profile.
  2. Mapped to risk. Each marker is linked to what it means for cardiovascular risk, using a physician-built clinical knowledge graph.
  3. Anchored to the evidence. Those relationships are checked against current guidelines and named trials — never vague “studies show.”
  4. Written in a physician's reasoning. Each read follows the same chain a clinician uses: the finding → what's optimal for you → why it matters → what changes it → what to discuss → where interpretation ends and your doctor begins.
  5. Kept current. As guidelines and major trials update, the underlying evidence base updates — and your interpretation reflects it.

What we anchor to

We cite sources, not vibes. The evidence base includes:

If a position changes in the guidelines, it changes here.

What CardioIQ is — and isn't

Being clear about the limits is part of the method. Plainly:

CardioIQ is

  • Physician-built and guideline-anchored
  • Calibrated to longevity-optimal targets and your risk
  • A clear, structured interpretation you can act on and take to your doctor
  • Kept current as the evidence moves

CardioIQ is not

  • A diagnosis or a medical device
  • A treatment plan or a promise of any outcome
  • A replacement for your physician, who makes every clinical decision
  • A regulatory-cleared clinical service

A tool that's honest about what a report can't do is one you can trust with what it does.

See your numbers read against optimal

Physician-grade interpretation, calibrated to your risk and built by a lipidologist — ApoB and Lp(a) included in the Standard report. Want a version formatted to bring to your doctor? That's the Premium report.

Choose your report Prefer the idea first? Read Normal vs Optimal Cholesterol →

Guideline anchors

  1. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455
  2. Mach F, Koskinas KC, Roeters van Lennep JE, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2025;46(42):4359–4378. doi:10.1093/eurheartj/ehaf190
  3. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a): an EAS consensus statement. European Heart Journal. 2022.
  4. ACC/AHA primary-prevention guidance; PREVENT risk equations.